Education
About Us
Working with TipRanks
Follow Us
Adhera Therapeutics (ATRX)
OTHER OTC:ATRX
ATRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume29.00
Average Volume (3M)43.00
Market Cap
$72.21K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-49.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.25
Shares Outstanding7,220,900
10 Day Avg. Volume0
30 Day Avg. Volume43
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ATRX FAQ
What was Adhera Therapeutics’s price range in the past 12 months?
Adhera Therapeutics lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Adhera Therapeutics’s market cap?
Adhera Therapeutics’s market cap is $72.21K.
When is Adhera Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adhera Therapeutics’s earnings last quarter?
Currently, no data Available
Is Adhera Therapeutics overvalued?
According to Wall Street analysts Adhera Therapeutics’s price is currently Overvalued.
Does Adhera Therapeutics pay dividends?
Adhera Therapeutics does not currently pay dividends.
What is Adhera Therapeutics’s EPS estimate?
Adhera Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adhera Therapeutics have?
Adhera Therapeutics has 7,220,900 shares outstanding.
What happened to Adhera Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adhera Therapeutics?
Currently, no hedge funds are holding shares in ATRX
Company Description
Adhera Therapeutics
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Adhera Therapeutics (ATRX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―